Saint Kitts and Nevis vs Tajikistan: Hepatitis B surface antigen (HBsAg) prevalence
Saint Kitts and Nevis
0.2%
in 2024
Tajikistan
0.2%
in 2024
Saint Kitts and Nevis rank
82nd
Tajikistan rank
82nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Saint Kitts and Nevis
- Tajikistan
How they compare
Saint Kitts and Nevis currently reports 0.2% against 0.2% in Tajikistan, a difference of 0.0%.
Across all 10 years both countries report, Tajikistan has been ahead every year.
Saint Kitts and Nevis ranks 82nd and Tajikistan ranks 82nd of 194 countries.
Tajikistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saint Kitts and Nevis | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | Tajikistan |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Saint Kitts and Nevis or Tajikistan?
- Saint Kitts and Nevis, at 0.2% against 0.2% in Tajikistan as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Saint Kitts and Nevis and Tajikistan?
- 0.0%, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Saint Kitts and Nevis and Tajikistan?
- 10 years are reported by both, from 2015 to 2024.
- How do Saint Kitts and Nevis and Tajikistan rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Saint Kitts and Nevis ranks 82nd and Tajikistan ranks 82nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.